Marwan Al-Hajeili, MD | Authors

MANAGED HLTH CARE ASSOCS

PO BOX 789

Articles

Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer

April 15, 2017

Recent improvements in our understanding of the biology of colorectal cancer have led to the identification of several important prognostic and predictive markers of disease-associated risk and treatment response for the individual patient.

Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer

January 16, 2016

Here, we review the studies that have explored different treatment regimens, therapeutic sequencing, and biologic inclusions for the treatment of these patients, with neoadjuvant intent. We also describe how we have established our own treatment paradigm for the management of potentially curable metastatic colorectal cancer.